Use of Anticoagulation Among Patients With Atrial Fibrillation or Atrial Flutter in the United States.
BACKGROUND Oral anticoagulation (OAC) remains underused in patients with atrial fibrillation or flutter at high risk of ischemic stroke. We aimed to characterize documented OAC prescribing at diagnosis and during 1-year follow-up and identify factors associated with baseline OAC prescribing. METHODS Using electronic...